The RejuvaHeart™ treatment deals with the entire body and it’s arterial flow. If we think of it in terms of the body being made up of 60 thousand miles of blood vessels, all of those blood vessels as we age, get more and more narrow. As the vessels get narrower, there’s less blood getting to the organs. Less blood is getting to the heart and if you get decrease in blood flow enough, you get a heart attack. If you don’t get enough blood flow to the genital area, which is part of the hydraulic mechanism, you are unable to get an erection. Read more about Erectile Dysfunction (E.D.)+
What the RejuvaHeart™ therapy does, is to improve not only the width of the blood vessels, but the inflammation in the blood vessels and allows them to be more pliable, allowing more blood flow into the organ and therefore making it more healthy.
Circulatory assistance provided by RejuvaHeart™ results in external augmentation pressure increasing coronary and systemic perfusion. RejuvaHeart™ may be indicated when physiological changes have reduced, or have the capacity to reduce, the heart’s pumping action. It may also be indicated when the quality of life is compromised due to ischemic heart disease.
The patient lies on a treatment table where compressive cuffs (similar to large blood pressure cuffs) are securely wrapped around the patient’s calves, thighs and buttocks. These cuffs inflate in a distal to proximal sequence in early diastole, and deflate simultaneously in late diastole just prior to the onset of systole. Inflation and deflation are specifically timed to the patient’s ECG to optimize therapeutic benefit.
Approximately 70% of myocardial perfusion with arterial blood occurs during diastole. It is during diastole that RejuvaHeart™ produces an increase in pressure within the aorta, increasing perfusion to the coronary arteries and to the arterial and vascular system. Relaxation of the cuff pressure during cardiac systole lowers the resistance to blood flow in the patient’s legs, reducing the back pressure on the heart as it ejects its bolus of blood. The combination of increased coronary flow (augmentation) and reduction of cardiac work (afterload) by RejuvaHeart™ improves cardiac function. The overall effect is to increase oxygen supply while reducing oxygen demand.
RejuvaHeart™ is typically provided in 35 one-hour treatment sessions over a period of approximately seven weeks. Additional hours may safely and effectively be prescribed if physician evaluation of the patient’s response to treatment determines additional sessions will result in greater relief of symptoms. In certain circumstances, adjusting the patient’s treatment regimen to two hours per day can make it more comfortable for the patient to complete a course of RejuvaHeart™.
